Use of activated recombinant factor VII in pediatric extracorporeal membrane oxygenation

Pediatric Critical Care Medicine

Volumn 11, Issue 4, 2010, Pages 537-538

  Walker, Alison ^a   Davidson, Mark ^a   Chalmers, Elizabeth ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

BLEEDING; ERYTHROCYTE TRANSFUSION; EXTRACORPOREAL OXYGENATION; HUMAN; LETTER; PLASMA TRANSFUSION; PRIORITY JOURNAL; RESPIRATORY FAILURE; THROMBOCYTE TRANSFUSION;

EID: 77954645503     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3181d4fe2c     Document Type: Letter

References (3)

1. Niebler RA, Punzalan RC, Marchan M, et al: Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation. Pediatr Crit Care Med 2010; 11: 98-102
2. Warren OJ, Rogers PL, Watret AL, et al: Defining the role of recombinant activated factor VII in pediatric cardiac surgery: Where should we go from here? Pediatr Crit Care Med 2009; 10:572-582
3. Novo Nordisk: NovoSeven. Electronic Medicines Compendium. June, 26, 2009. Available at http://emc.medicines.org.uk/medicine/ 21171/SPC/NovoSeven. Accessed February 1, 2010